BlackRock Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,193,917
-32.8%
8,893,980
+5.3%
0.00%0.0%
Q2 2023$41,976,869
-6.9%
8,446,050
-7.4%
0.00%0.0%
Q1 2023$45,068,073
-19.4%
9,123,092
+2.7%
0.00%
-50.0%
Q4 2022$55,896,538
-37.0%
8,886,572
+8.2%
0.00%
-33.3%
Q3 2022$88,696,000
-2.8%
8,212,580
+2.6%
0.00%0.0%
Q2 2022$91,260,000
+41.4%
8,005,166
+13.0%
0.00%
+50.0%
Q1 2022$64,557,000
-33.7%
7,086,233
+8.6%
0.00%0.0%
Q4 2021$97,368,000
-47.9%
6,525,954
-10.2%
0.00%
-60.0%
Q3 2021$186,868,000
+2.0%
7,271,192
+3.5%
0.01%0.0%
Q2 2021$183,132,000
-17.3%
7,021,939
+12.0%
0.01%
-28.6%
Q1 2021$221,334,000
+35.5%
6,270,078
-3.1%
0.01%
+40.0%
Q4 2020$163,372,000
-31.4%
6,472,760
+2.5%
0.01%
-44.4%
Q3 2020$238,051,000
-4.0%
6,312,703
+9.0%
0.01%
-10.0%
Q2 2020$248,017,000
+160.2%
5,792,119
+18.1%
0.01%
+100.0%
Q1 2020$95,305,000
-27.0%
4,902,584
-2.4%
0.01%0.0%
Q4 2019$130,544,000
+19.6%
5,024,772
+25.5%
0.01%0.0%
Q3 2019$109,130,000
+14.1%
4,004,019
+12.4%
0.01%
+25.0%
Q2 2019$95,650,000
+47.0%
3,562,333
+58.3%
0.00%
+33.3%
Q1 2019$65,056,000
+16.1%
2,250,277
+8.2%
0.00%0.0%
Q4 2018$56,011,0002,079,8290.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders